{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:47:58Z","timestamp":1792691278913,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kraeftens Bekaempelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.radonc.2024.110284","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T23:49:12Z","timestamp":1713311352000},"page":"110284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin"],"prefix":"10.1016","volume":"196","author":[{"given":"Ruta","family":"Zukauskaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Horsholt","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Grau","family":"Eriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Sams\u00f8e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Kj\u00e6r","family":"L\u00f8nkvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Grau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R\u00f8nn","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110284_b0005","first-page":"183","article-title":"Treatment of oropharyngeal squamous cell carcinoma: Is swallowing quality better after TORS or RT?","author":"Campo","year":"2023","journal-title":"Radioth Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0010","doi-asserted-by":"crossref","unstructured":"Al-Mamgani A, Kessels R, Navran A, et al. Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes. Radiotherapy and Oncology. 2021 2021\/09\/01\/;162:170-177.","DOI":"10.1016\/j.radonc.2021.07.016"},{"key":"10.1016\/j.radonc.2024.110284_b0015","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): An updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105030","article-title":"Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging","volume":"111","author":"Contrera","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2022.08.013","article-title":"Disease outcome and associated factors after definitive platinum based chemoradiotherapy for advanced stage HPV-negative head and neck cancer","volume":"175","author":"de Roest","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0030","doi-asserted-by":"crossref","first-page":"e2241538","DOI":"10.1001\/jamanetworkopen.2022.41538","article-title":"Toxicity profiles and survival outcomes among patients with nonmetastatic oropharyngeal carcinoma treated with intensity-modulated proton therapy vs intensity-modulated radiation therapy","volume":"5","author":"Youssef","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2024.110284_b0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2017.11.024","article-title":"Local recurrences after curative IMRT for HNSCC: Effect of different GTV to high-dose CTV margins","volume":"126","author":"Zukauskaite","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.radonc.2018.06.032","article-title":"The impact of margin reduction on outcome and toxicity in head and neck cancer patients treated with image-guided volumetric modulated arc therapy (VMAT)","volume":"130","author":"Navran","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.radonc.2022.01.013","article-title":"The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction","volume":"168","author":"Al-Mamgani","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2017.09.019","article-title":"Consequences of introducing geometric GTV to CTV margin expansion in DAHANCA contouring guidelines for head and neck radiotherapy","volume":"126","author":"Hansen","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0060","unstructured":"https:\/\/www.dahanca.dk\/uploads\/TilFagfolk\/Guideline\/GUID_DAHANCA_Radiotherapy_guidelines_2020.pdf."},{"key":"10.1016\/j.radonc.2024.110284_b0065","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1080\/0284186X.2017.1346384","article-title":"Analysis of CT-verified loco-regional recurrences after definitive IMRT for HNSCC using site of origin estimation methods","volume":"56","author":"Zukauskaite","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/0284186X.2015.1117136","article-title":"Failure pattern and salvage treatment after radical treatment of head and neck cancer","volume":"55","author":"Pagh","year":"2016","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0075","doi-asserted-by":"crossref","unstructured":"Rohde M, Rosenberg T, Pareek M, et al. Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense\u2013Birmingham definition. European Archives of Oto-Rhino-Laryngology. 2020 2020\/06\/01;277(6):1593-1599.","DOI":"10.1007\/s00405-020-05953-5"},{"key":"10.1016\/j.radonc.2024.110284_b0080","first-page":"1","article-title":"A national repository of complete radiotherapy plans: design, Results, and experiences","volume":"18","author":"Krogh","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0085","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00066-016-0998-4","article-title":"Open source deformable image registration system for treatment planning and recurrence CT scans : Validation in the head and neck region","volume":"192","author":"Zukauskaite","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2024.110284_b0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.phro.2022.06.012","article-title":"Co-registration of radiotherapy planning and recurrence scans with different imaging modalities in head and neck cancer","volume":"23","author":"Kristensen","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0095","doi-asserted-by":"crossref","unstructured":"Welz S, Paulsen F, Pfannenberg C, et al. Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET\/CT. Radiotherapy and Oncology. 2022 2022\/06\/01\/;171:30-36.","DOI":"10.1016\/j.radonc.2022.03.021"},{"key":"10.1016\/j.radonc.2024.110284_b0100","first-page":"186","article-title":"An efficient strategy to select head and neck cancer patients for adaptive radiotherapy","author":"Gan","year":"2023","journal-title":"Radioth Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0105","doi-asserted-by":"crossref","unstructured":"Sher DJ, Pham N-L, Shah JL, et al. Prospective Phase 2 Study of Radiation Therapy Dose and Volume De-escalation for Elective Neck Treatment of Oropharyngeal and Laryngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 2021 2021\/03\/15\/;109(4):932-940.","DOI":"10.1016\/j.ijrobp.2020.09.063"},{"key":"10.1016\/j.radonc.2024.110284_b0110","article-title":"Evaluation of decentralised model-based selection of head and neck cancer patients for a proton treatment study. DAHANCA 35","author":"Hansen","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0115","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1200\/JCO.21.01961","article-title":"Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: Long-term results of the ORATOR trial","volume":"40","author":"Nichols","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13014-017-0829-5","article-title":"Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer","volume":"12","author":"Johansen","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.oraloncology.2015.08.004","article-title":"Analysis of loco-regional failures in head and neck cancer after radical radiation therapy","volume":"51","author":"De Felice","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/jamaoncol.2017.0973","article-title":"Patterns of treatment failure and postrecurrence outcomes among patients with locally advanced head and neck squamous cell carcinoma after chemoradiotherapy using modern radiation techniques","volume":"3","author":"Leeman","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"Gregoire","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2009.01.037","article-title":"Margin on gross tumor volume and risk of local recurrence in head-and-neck cancer","volume":"76","author":"Caudell","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110284_b0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nrc2419","article-title":"Exploring the role of cancer stem cells in radioresistance","volume":"8","author":"Baumann","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2024.110284_b0150","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1259\/bjr\/22373346","article-title":"Volumetric modulated arc therapy: a review of current literature and clinical use in practice","volume":"84","author":"Teoh","year":"2011","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2024.110284_b0155","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00066-012-0127-y","article-title":"Methods for estimating the site of origin of locoregional recurrence in head and neck squamous cell carcinoma","volume":"188","author":"Due","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2024.110284_b0160","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2012.02.042","article-title":"Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma","volume":"85","author":"Raktoe","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110284_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13014-015-0345-4","article-title":"Assessment and topographic characterization of locoregional recurrences in head and neck tumours","volume":"15","author":"Ferreira","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0170","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.radonc.2014.06.001","article-title":"Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake","volume":"111","author":"Due","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0175","doi-asserted-by":"crossref","unstructured":"H\u00e5kansson K, Lindegaard AM, Bernsdorf M, et al. A comparison of loco-regional relapse pattern in HPV positive vs negative oropharyngeal cancers following radiotherapy; relation to pretreatment FDG-PET and radiotherapy target volumes. Acta Oncologica. 2023 2023\/09\/02;62(9):1028-1035.","DOI":"10.1080\/0284186X.2023.2238889"},{"key":"10.1016\/j.radonc.2024.110284_b0180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.radonc.2016.03.005","article-title":"Phase I trial of 18F-Fludeoxyglucose based radiation dose painting with concomitant cisplatin in head and neck cancer","volume":"120","author":"Rasmussen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109629","article-title":"Outcome prediction models incorporating clinical variables for Head and Neck Squamous cell Carcinoma: A systematic review of methodological conduct and risk of bias","volume":"183","author":"Aly","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109763","article-title":"An efficient strategy to select head and neck cancer patients for adaptive radiotherapy","volume":"186","author":"Gan","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110284_b0195","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1002\/cncr.33212","article-title":"Predictive classifier for intensive treatment of head and neck cancer","volume":"126","author":"Zakeri","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110284_b0200","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/09553002.2019.1589013","article-title":"Proliferation saturation index in an adaptive Bayesian approach to predict patient-specific radiotherapy responses","volume":"95","author":"Sunassee","year":"2019","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2024.110284_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2021.05.005","article-title":"Something for everyone from low-risk to high-risk: 5 recent studies to improve treatment and surveillance for all patients with squamous cell carcinoma of the head and neck","volume":"111","author":"Mierzwa","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024002068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024002068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:11:46Z","timestamp":1731028306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024002068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"alternative-id":["S0167814024002068"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110284","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of 3-year local control using DAHANCA radiotherapy guidelines before and after implementation of five millimetres geometrical GTV to high-dose CTV margin","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110284"}}